Poly Medicure
- Advice
- Hold
Poly Medicure Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Poly Medicure
Start SIPPoly Medicure Investment Rating
-
Master Rating:
-
Poly Medicure has an operating revenue of Rs. 1,065.89 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 21% is great, ROE of 13% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 7% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -7% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 37 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 272 | 264 | 239 | 244 |
| Operating Expenses Qtr Cr | 203 | 198 | 191 | 188 |
| Operating Profit Qtr Cr | 68 | 66 | 48 | 57 |
| Depreciation Qtr Cr | 14 | 14 | 14 | 14 |
| Interest Qtr Cr | 5 | 0 | 1 | 1 |
| Tax Qtr Cr | 17 | 16 | 9 | 13 |
| Net Profit Qtr Cr | 48 | 45 | 29 | 38 |
Poly Medicure Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- 955.21
- 50 Day
- 937.42
- 100 Day
- 920.28
- 200 Day
- 896.1
- 20 Day
- 965.49
- 50 Day
- 921.28
- 100 Day
- 927.32
- 200 Day
- 872.85
Poly Medicure Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 991.59 |
| Second Resistance | 1011.37 |
| Third Resistance | 1033.64 |
| RSI | 48.33 |
| MFI | 62.39 |
| MACD Single Line | 11.2 |
| MACD | 7.41 |
| Support | |
|---|---|
| First Resistance | 949.54 |
| Second Resistance | 927.27 |
| Third Resistance | 907.49 |
Poly Medicure Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 81,603 | 3,832,077 | 46.96 |
| Week | 58,477 | 2,451,347 | 41.92 |
| 1 Month | 123,205 | 3,409,080 | 27.67 |
| 6 Month | 57,360 | 1,955,415 | 34.09 |
Poly Medicure Result Highlights
Poly Medicure Synopsis
NSE-Medical-Systems/Equip
Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 879.36 Cr. and Equity Capital is Rs. 47.95 Cr. for the Year ended 31/03/2022. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.| Market Cap | 9,039 |
| Sales | 1,019 |
| Shares in Float | 4.51 |
| No of funds | 95 |
| Yield | 0.27 |
| Book Value | 8.39 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 3 |
| Alpha | 0.04 |
| Beta | 0.53 |
Poly Medicure
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 53.33% | 53.33% | 53.34% | |
| Mutual Funds | 3.01% | 3.03% | 2.92% | |
| Insurance Companies | 0.18% | 0.18% | 0.18% | |
| Foreign Portfolio Investors | 16.33% | 16.27% | 15.59% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 11.18% | 11.2% | 11.93% | |
| Others | 15.97% | 15.99% | 16.04% |
Poly Medicure Management
| Name | Designation |
|---|---|
| Mr. Devendra Raj Mehta | Chairman |
| Mr. Himanshu Baid | Managing Director |
| Mr. Rishi Baid | Joint Managing Director |
| Mr. Jugal Kishore Baid | Non Executive Director |
| Mrs. Mukulika Baid | Non Executive Director |
| Mr. Alessandro Balboni | Non Executive Director |
| Dr. Sandeep Bhargava | Ind. Non-Executive Director |
| Mr. Amit Khosla | Ind. Non-Executive Director |
| Ms. Sonal Mattoo | Ind. Non-Executive Director |
| Mr. Prakash Chand Surana | Ind. Non-Executive Director |
| Dr. Shailendra Raj Mehta | Ind. Non-Executive Director |
| Dr. Ambrish Mithal | Additional Director |
Poly Medicure Forecast
Price Estimates
Poly Medicure FAQs
What is Share Price of Poly Medicure ?
Poly Medicure share price is ₹941 As on 30 March, 2023 | 13:52
What is the Market Cap of Poly Medicure ?
The Market Cap of Poly Medicure is ₹9039 Cr As on 30 March, 2023 | 13:52
What is the P/E ratio of Poly Medicure ?
The P/E ratio of Poly Medicure is 57.7 As on 30 March, 2023 | 13:52
What is the PB ratio of Poly Medicure ?
The PB ratio of Poly Medicure is 8.3 As on 30 March, 2023 | 13:52